Dapagliflozin 5 & 10 Mg Adco 5mg, 10 mg FC TABLETS

Dapagliflozin 5 & 10 Mg Adco 5mg, 10 mg FC TABLETS

S4
PDF Leaflet Revision Date: 11 March 2025

API: Dapagliflozin | Company: Adcock Ingram

Clinical Summary

Quick overview from the medicine insert

Indication

Type 2 diabetes mellitus and heart failure.

Dosage (summary)

10 mg once daily for adults.

Special Populations

  • Renal impairment
  • Hepatic impairment
  • Elderly

Pregnancy & Breastfeeding

Contraindicated in pregnancy and breastfeeding.

Key Drug Interactions

  • Insulin
  • Sulphonylureas
  • Diuretics

Contraindications

  • Type 1 diabetes
  • Hypersensitivity
  • History of pancreatitis

Common side effects

  • Genital infections
  • Urinary tract infections
  • Hypoglycaemia

Counselling Points

  • Monitor for signs of ketoacidosis
  • Stay hydrated
  • Report genital infections

Serious warnings

  • Risk of diabetic ketoacidosis
  • Necrotising fasciitis
  • Volume depletion
Important Disclaimer

The Dapagliflozin 5 & 10 Mg Adco 5mg, 10 mg FC TABLETS professional information leaflet below is the property of Adcock Ingram and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>

Healthcare Professionals Only

This content is for registered healthcare professionals

Sign in or create a free account to read the full package insert.

Free for HPCSA-registered professionals. Powered by Medinsert.

Successfully Stashed! 💊

This package insert has been safely stored in your digital medical cabinet. No prescription needed to view it later!

View My Favourites